Enliven Therapeutics, Inc. logo

Enliven Therapeutics, Inc. (ELVN)

Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
57. 86
-0.03
-0.0518%
After Hours
$
59. 97
+2.11 +3.6467%
4.14B Market Cap
- P/E Ratio
- Div Yield
1.04M Volume
-2.36 Eps
$ 57.89
Previous Close
Add Transaction
Day Range
57.23 58.34
Year Range
14.79 62.32
Want to track ELVN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Enliven Therapeutics, Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Winfried Buchbauer
Winfried Buchbauer Erste Asset Management GmbH
25,000 $1.27M $1.37M $99,000 7.79%
Zachary Canonico
Zachary Canonico DIADEMA PARTNERS LP
10,000 $504,670.25 $588,200 $83,529.75 16.55%
AMY TEH
AMY TEH Arrowpoint Investment Partners (Singapore) Pte. Ltd.
4,499 $228,324 $260,582.08 $32,258.08 14.13%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
12,635 $316,017.07 $692,524.35 $376,507.28 119.14%
William Staveacre
William Staveacre Aster Capital Management (DIFC) Ltd.
28,584 $1.45M $1.66M $202,088.88 13.9%
Scott Schroeder
Scott Schroeder Longaeva Partners LP
312,560 $14.56M $18.38M $3.83M 26.3%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
9,433 $402,425.32 $570,319.18 $167,893.86 41.72%
WJ
William Jones TEMA ETFs LLC
60,694 $2.58M $3.33M $743,714.49 28.79%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
1,258 $30,429.52 $76,058.68 $45,629.16 149.95%